Boston Trust Walden Corp Lowers Stake in CorVel Co. (NASDAQ:CRVL)

Boston Trust Walden Corp reduced its position in CorVel Co. (NASDAQ:CRVL) by 4.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 232,515 shares of the business services provider’s stock after selling 10,023 shares during the quarter. Boston Trust Walden Corp’s holdings in CorVel were worth $76,007,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of CRVL. Blue Trust Inc. increased its stake in CorVel by 435.3% in the 3rd quarter. Blue Trust Inc. now owns 91 shares of the business services provider’s stock worth $30,000 after buying an additional 74 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of CorVel by 98.0% in the second quarter. GAMMA Investing LLC now owns 97 shares of the business services provider’s stock worth $25,000 after acquiring an additional 48 shares during the period. Whittier Trust Co. of Nevada Inc. purchased a new stake in shares of CorVel during the third quarter worth about $102,000. Benjamin F. Edwards & Company Inc. raised its stake in CorVel by 130.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 411 shares of the business services provider’s stock valued at $105,000 after purchasing an additional 233 shares during the period. Finally, Kapitalo Investimentos Ltda bought a new stake in CorVel during the 3rd quarter valued at approximately $208,000. 51.36% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CorVel

In related news, EVP Mark E. Bertels sold 300 shares of the firm’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $299.80, for a total value of $89,940.00. Following the completion of the transaction, the executive vice president now directly owns 858 shares of the company’s stock, valued at approximately $257,228.40. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other CorVel news, EVP Mark E. Bertels sold 300 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $299.80, for a total transaction of $89,940.00. Following the sale, the executive vice president now directly owns 858 shares in the company, valued at $257,228.40. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Alan Hoops sold 1,700 shares of CorVel stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $300.00, for a total value of $510,000.00. Following the completion of the transaction, the director now owns 9,396 shares of the company’s stock, valued at approximately $2,818,800. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 19,893 shares of company stock valued at $6,003,958 in the last ninety days. Corporate insiders own 47.57% of the company’s stock.

CorVel Stock Down 0.0 %

NASDAQ CRVL traded down $0.09 on Friday, reaching $304.01. The company had a trading volume of 14,344 shares, compared to its average volume of 36,450. The firm’s 50 day moving average price is $313.50 and its 200 day moving average price is $280.26. CorVel Co. has a 12 month low of $187.92 and a 12 month high of $329.23. The stock has a market capitalization of $5.22 billion, a PE ratio of 69.09 and a beta of 1.08.

CorVel (NASDAQ:CRVL) last posted its earnings results on Tuesday, July 30th. The business services provider reported $1.25 EPS for the quarter. The company had revenue of $211.72 million for the quarter. CorVel had a return on equity of 32.25% and a net margin of 9.55%.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a report on Saturday, August 31st.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.